Abstract
B cells have long been understood to be drivers of both humoral and cellular immunity. Recent advances underscore this importance but also indicate that in infection, inflammatory disease and cancer, B cells function directly at sites of inflammation and form tissue-resident memory populations. The spatial organization and cellular niches of tissue B cells have profound effects on their function and on disease outcome, as well as on patient response to therapy. Here we review the role of B cells in peripheral tissues in homeostasis and disease, and discuss the newly identified cellular and molecular signals that are involved in regulating their activity. We integrate emerging data from multi-omic human studies with experimental models to propose a framework for B cell function in tissue inflammation and homeostasis.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Allie, S. R. et al. The establishment of resident memory B cells in the lung requires local antigen encounter. Nat. Immunol. 20, 97–108 (2019). This is the first report (to our knowledge) to use parabiosis to provide definitive evidence of memory B cell residency following influenza virus lung infection.
Onodera, T. et al. Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection. Proc. Natl Acad. Sci. USA 109, 2485–2490 (2012).
Barker, K. A. et al. Lung-resident memory B cells protect against bacterial pneumonia. J. Clin. Investig. 131, e141810 (2021). The first study (to our knowledge) to demonstrate that bacterial lung infection induces lung BRM cells that are protective against lethal bacterial rechallenge.
Chen, J. et al. Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer. Genome Biol. 21, 152 (2020).
Trim, W. V. & Lynch, L. Immune and non-immune functions of adipose tissue leukocytes. Nat. Rev. Immunol. 22, 371–386 (2022).
Brioschi, S. et al. Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders. Science 373, eabf9277 (2021).
Geherin, S. A. et al. The skin, a novel niche for recirculating B cells. J. Immunol. 188, 6027–6035 (2012).
Baumgarth, N. The shaping of a B cell pool maximally responsive to infections. Annu. Rev. Immunol. 39, 103–129 (2021).
Shahaf, G., Zisman-Rozen, S., Benhamou, D., Melamed, D. & Mehr, R. B cell development in the bone marrow is regulated by homeostatic feedback exerted by mature B cells. Front. Immunol. 7, 77 (2016).
Cyster, J. G. & Allen, C. D. C. B cell responses: cell interaction dynamics and decisions. Cell 177, 524–540 (2019).
Rastogi, I. et al. Role of B cells as antigen presenting cells. Front. Immunol. 13, 954936 (2022).
Michaud, D., Steward, C. R., Mirlekar, B. & Pylayeva-Gupta, Y. Regulatory B cells in cancer. Immunol. Rev. 299, 74–92 (2021).
Laumont, C. M. & Nelson, B. H. B cells in the tumor microenvironment: multi-faceted organizers, regulators, and effectors of anti-tumor immunity. Cancer Cell 41, 466–489 (2023).
Upasani, V., Rodenhuis-Zybert, I. & Cantaert, T. Antibody-independent functions of B cells during viral infections. PLoS Pathog. 17, e1009708 (2021).
Tan, H.-X. et al. Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles. Sci. Immunol. 7, eabf5314 (2022).
Inoue, T. & Kurosaki, T. Memory B cells. Nat. Rev. Immunol. 24, 5–17 (2024).
Chung, M. K. Y. et al. Functions of double-negative B cells in autoimmune diseases, infections, and cancers. EMBO Mol. Med. 15, e17341 (2023).
Elsner, R. A. & Shlomchik, M. J. Germinal center and extrafollicular B cell responses in vaccination, immunity, and autoimmunity. Immunity 53, 1136–1150 (2020).
Roco, J. A. et al. Class-switch recombination occurs infrequently in germinal centers. Immunity 51, 337–350.e337 (2019).
Bergqvist, P., Stensson, A., Lycke, N. Y. & Bemark, M. T cell-independent IgA class switch recombination is restricted to the GALT and occurs prior to manifest germinal center formation. J. Immunol. 184, 3545–3553 (2010).
Horns, F. et al. Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching. eLife 5, e16578 (2016).
Laidlaw, B. J. & Cyster, J. G. Transcriptional regulation of memory B cell differentiation. Nat. Rev. Immunol. 21, 209–220 (2021).
Li, Y., Li, Z. & Hu, F. Double-negative (DN) B cells: an under-recognized effector memory B cell subset in autoimmunity. Clin. Exp. Immunol. 205, 119–127 (2021).
Ma, J. et al. A blueprint for tumor-infiltrating B cells across human cancers. Science 384, eadj4857 (2024). Comprehensive multi-omic analysis of tumour-infiltrating B cells across 20 cancer types.
Zuccarino-Catania, G. V. et al. CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. Nat. Immunol. 15, 631–637 (2014).
Dogan, I. et al. Multiple layers of B cell memory with different effector functions. Nat. Immunol. 10, 1292–1299 (2009).
Pape, K. A., Taylor, J. J., Maul, R. W., Gearhart, P. J. & Jenkins, M. K. Different B cell populations mediate early and late memory during an endogenous immune response. Science 331, 1203–1207 (2011).
Mesin, L. et al. Restricted clonality and limited germinal center reentry characterize memory B cell reactivation by boosting. Cell 180, 92–106 e111 (2020).
Alsoussi, W. B. et al. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans. Nature 617, 592–598 (2023).
Turner, J. S. et al. Human germinal centres engage memory and naive B cells after influenza vaccination. Nature 586, 127–132 (2020).
Cancro, M. P. Age-associated B cells. Annu. Rev. Immunol. 38, 315–340 (2020).
Dai, D. et al. The transcription factor ZEB2 drives the formation of age-associated B cells. Science 383, 413–421 (2024).
Gao, X. et al. Zeb2 drives the formation of CD11c+ atypical B cells to sustain germinal centers that control persistent infection. Sci. Immunol. 9, eadj4748 (2024).
Nellore, A. et al. A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination in humans. Immunity 56, 847–863.e848 (2023).
Arroyo-Diaz, N. M. et al. Interferon-gamma production by Tfh cells is required for CXCR3+ pre-memory B cell differentiation and subsequent lung-resident memory B cell responses. Immunity 56, 2358–2372.e2355 (2023).
Song, W. et al. Development of Tbet- and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers. Immunity 55, 290–307 e295 (2022).
Castleman, M. J. et al. Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells. Front. Immunol. 13, 988125 (2022).
Sutton, H. J. et al. Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans. Cell Rep. 34, 108684 (2021).
Bemark, M. et al. Limited clonal relatedness between gut IgA plasma cells and memory B cells after oral immunization. Nat. Commun. 7, 12698 (2016).
Shang, L. et al. Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology 135, 529–538 (2008).
Silva-Sanchez, A. & Randall, T. D. in Mucosal Vaccines 2nd edn (eds Kiyono, H. & Pascual, D. W.) Ch. 2 (Academic Press, 2020).
Hand, T. W. & Reboldi, A. Production and function of immunoglobulin A. Annu. Rev. Immunol. 39, 695–718 (2021).
Sato, Y., Silina, K., van den Broek, M., Hirahara, K. & Yanagita, M. The roles of tertiary lymphoid structures in chronic diseases. Nat. Rev. Nephrol. 19, 525–537 (2023).
Fridman, W. H. et al. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nat. Rev. Clin. Oncol. 19, 441–457 (2022).
Gribonika, I. et al. Skin autonomous antibody production regulates host-microbiota interactions. Nature https://doi.org/10.1038/s41586-024-08376-y (2024).
Randall, T. D. & Mebius, R. E. The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms. Mucosal Immunol. 7, 455–466 (2014).
MacFawn, I. P. et al. The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell 42, 1864–1881.e1865 (2024).
Allie, S. R. & Randall, T. D. Resident memory B cells. Viral Immunol. 33, 282–293 (2020).
Chen, C. & Laidlaw, B. J. Development and function of tissue-resident memory B cells. Adv. Immunol. 155, 1–38 (2022).
Gray, J. I. & Farber, D. L. Tissue-resident immune cells in humans. Annu. Rev. Immunol. 40, 195–220 (2022).
Weisel, N. M. et al. Comprehensive analyses of B-cell compartments across the human body reveal novel subsets and a gut-resident memory phenotype. Blood 136, 2774–2785 (2020).
Ramirez, S. I. et al. Immunological memory diversity in the human upper airway. Nature 632, 630–636 (2024).
Oh, J. E. et al. Migrant memory B cells secrete luminal antibody in the vagina. Nature 571, 122–126 (2019).
Lee, C. M. & Oh, J. E. Resident memory B cells in barrier tissues. Front. Immunol. 13, 953088 (2022).
Reusch, L. & Angeletti, D. Memory B-cell diversity: from early generation to tissue residency and reactivation. Eur. J. Immunol. 53, e2250085 (2023).
Madissoon, E. et al. A spatially resolved atlas of the human lung characterizes a gland-associated immune niche. Nat. Genet. 55, 66–77 (2023).
Oh, J. E. et al. Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA. Sci. Immunol. 6, eabj5129 (2021). Evidence of lung IgA+ BRM cell and IgA+ plasma cell requirements for protection against influenza virus infection independent of T cells.
MacLean, A. J. et al. Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites. Immunity 55, 718–733.e718 (2022).
MacLean, A. J. et al. Regulation of pulmonary plasma cell responses during secondary infection with influenza virus. J. Exp. Med. 221, e20232014 (2024). This study demonstrates the presence of BRM cell subsets in lung niches and the mechanisms of their differences in recall response kinetics.
Gregoire, C. et al. Viral infection engenders bona fide and bystander subsets of lung-resident memory B cells through a permissive mechanism. Immunity 55, 1216–1233.e1219 (2022).
Poon, M. M. L. et al. SARS-CoV-2 infection generates tissue-localized immunological memory in humans. Sci. Immunol. 6, eabl9105 (2021).
Bowyer, G. S., Loudon, K. W., Suchanek, O. & Clatworthy, M. R. Tissue immunity in the bladder. Annu. Rev. Immunol. 40, 499–523 (2022).
Ichii, O. et al. Close association between altered urine-urothelium barrier and tertiary lymphoid structure formation in the renal pelvis during nephritis. J. Am. Soc. Nephrol. 33, 88–107 (2022).
Kawashima, K., Andreata, F., Beccaria, C. G. & Iannacone, M. Priming and maintenance of adaptive immunity in the liver. Annu. Rev. Immunol. 42, 375–399 (2024).
Mahanonda, R. et al. Human memory B cells in healthy gingiva, gingivitis, and periodontitis. J. Immunol. 197, 715–725 (2016).
Yenson, V. & Baumgarth, N. Purification and immune phenotyping of B-1 cells from body cavities of mice. Methods Mol. Biol. 2270, 27–45 (2021).
Wilson, E. & Butcher, E. C. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J. Exp. Med. 200, 805–809 (2004).
Havervall, S. et al. Anti-spike mucosal IgA protection against SARS-CoV-2 Omicron infection. N. Engl. J. Med. 387, 1333–1336 (2022).
Pisanic, N. et al. Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is associated with faster viral clearance and COVID-19 symptom resolution. J. Infect. Dis. https://doi.org/10.1093/infdis/jiae447 (2024).
Yel, L. Selective IgA deficiency. J. Clin. Immunol. 30, 10–16 (2010).
Silva-Sanchez, A. & Randall, T. D. Role of iBALT in respiratory immunity. Curr. Top. Microbiol. Immunol. 426, 21–43 (2020).
Matsumoto, R. et al. Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity. Nat. Immunol. 24, 1370–1381 (2023).
Moyron-Quiroz, J. E. et al. Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 25, 643–654 (2006).
Landsverk, O. J. et al. Antibody-secreting plasma cells persist for decades in human intestine. J. Exp. Med. 214, 309–317 (2017).
Robinson, M. J., Webster, R. H. & Tarlinton, D. M. How intrinsic and extrinsic regulators of plasma cell survival might intersect for durable humoral immunity. Immunol. Rev. 296, 87–103 (2020).
Trivedi, N. et al. Liver is a generative site for the B cell response to Ehrlichia muris. Immunity 51, 1088–1101.e1085 (2019).
Cai, Y. & Yin, W. The multiple functions of B cells in chronic HBV infection. Front. Immunol. 11, 582292 (2020).
Burton, A. R. et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J. Clin. Investig. 128, 4588–4603 (2018).
Suchanek, O. et al. Tissue-resident B cells orchestrate macrophage polarisation and function. Nat. Commun. 14, 7081 (2023).
Stark, A. K. et al. PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner. Nat. Commun. 9, 3174 (2018).
Mutnal, M. B., Hu, S. & Lokensgard, J. R. Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirus. PLoS ONE 7, e33143 (2012).
Cohen, S. B., Gern, B. H. & Urdahl, K. B. The tuberculous granuloma and preexisting immunity. Annu. Rev. Immunol. 40, 589–614 (2022).
Khader, S. A. et al. IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J. Immunol. 187, 5402–5407 (2011).
Krause, R. et al. B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles. Commun. Biol. 7, 584 (2024).
Swanson, R. V. et al. Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control. Nat. Immunol. 24, 855–868 (2023).
Stewart, P. et al. Role of B cells in Mycobacterium tuberculosis infection. Vaccines 11, 955 (2023).
Davis-Porada, J. et al. Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues. Immunity 12, 2895–2913.e8 (2024).
Gao, X. & Cockburn, I. A. The development and function of CD11c+ atypical B cells — insights from single cell analysis. Front. Immunol. 13, 979060 (2022).
Adachi, Y. et al. Distinct germinal center selection at local sites shapes memory B cell response to viral escape. J. Exp. Med. 212, 1709–1723 (2015).
Raso, F. et al. Antigen receptor signaling and cell death resistance controls intestinal humoral response zonation. Immunity 56, 2373–2387.e2378 (2023).
Etesami, N. S. et al. B cells in the pneumococcus-infected lung are heterogeneous and require CD4+ T cell help including CD40L to become resident memory B cells. Front. Immunol. 15, 1382638 (2024).
Swarnalekha, N. et al. T resident helper cells promote humoral responses in the lung. Sci. Immunol. 6, eabb6808 (2021).
Liu, J. et al. Turbinate-homing IgA-secreting cells originate in the nasal lymphoid tissues. Nature 632, 637–646 (2024).
Lowe, M. M. et al. Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa. JCI Insight 9, e169870 (2024).
Lowe, M. M. et al. Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy. JCI Insight 5, e139932 (2020).
Gudjonsson, J. E. et al. Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis. JCI Insight 5, e139930 (2020).
Yadav, R. et al. IL-12/IL-23 blockade reveals patterns of asynchronous inflammation in pyoderma gangrenosum. J. Investig. Dermatol. https://doi.org/10.1016/j.jid.2024.08.040 (2024).
Han, D. et al. Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blisters. J. Clin. Investig. 133, ejci166357 (2023).
Carmona-Rivera, C. et al. Autoantibodies present in hidradenitis suppurativa correlate with disease severity and promote the release of proinflammatory cytokines in macrophages. J. Investig. Dermatol. 142, 924–935 (2022).
Sabat, R. et al. Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa. J. Allergy Clin. Immunol. 151, 1015–1026 (2023).
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E. & Aloisi, F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14, 164–174 (2004).
Farahnak, K. et al. B cells mediate lung ischemia/reperfusion injury by recruiting classical monocytes via synergistic B cell receptor/TLR4 signaling. J. Clin. Investig. 134, e170118 (2024).
Zhang, G. et al. Lymphotoxin β receptor and tertiary lymphoid organs shape acute and chronic allograft rejection. JCI Insight 9, e177555 (2024).
Humby, F. et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 6, e1 (2009).
Lehmann-Horn, K., Wang, S. Z., Sagan, S. A., Zamvil, S. S. & von Büdingen, H. C. B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue. JCI Insight 1, e87234 (2016).
Zhang, Y. et al. B cell-activating factor and its targeted therapy in autoimmune diseases. Cytokine Growth Factor. Rev. 64, 57–70 (2022).
Pröbstel, A. K. et al. Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis. Sci. Immunol. 5, eabc7191 (2020).
Rojas, O. L. et al. Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10. Cell 176, 610–624.e618 (2019).
Winer, D. A. et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 17, 610–617 (2011).
Hägglöf, T. et al. T-bet+ B cells accumulate in adipose tissue and exacerbate metabolic disorder during obesity. Cell Metab. 34, 1121–1136.e1126 (2022).
He, Y. & Vinuesa, C. G. Germinal center versus extrafollicular responses in systemic autoimmunity: who turns the blade on self? Adv. Immunol. 162, 109–133 (2024).
Allard-Chamard, H. et al. Extrafollicular IgD−CD27−CXCR5−CD11c− DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19. Cell Rep. 42, 112630 (2023).
Dunlap, G. et al. Clonal associations between lymphocyte subsets and functional states in rheumatoid arthritis synovium. Nat. Commun. 15, 4991 (2024).
Yeo, L. et al. Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis. Ann. Rheum. Dis. 74, 928–935 (2015).
Elsner, R. A., Smita, S. & Shlomchik, M. J. IL-12 induces a B cell-intrinsic IL-12/IFNγ feed-forward loop promoting extrafollicular B cell responses. Nat. Immunol. 25, 1283–1295 (2024).
Teng, M. W. et al. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat. Med. 21, 719–729 (2015).
Cabrita, R. et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577, 561–565 (2020). This study, together with Petitprez et al. 2020 and Helmink et al. 2020, shows that the presence and maturation state of TLSs is strongly associated with prognosis and immunotherapy response of patients with cancer.
Laumont, C. M., Banville, A. C., Gilardi, M., Hollern, D. P. & Nelson, B. H. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat. Rev. Cancer 22, 414–430 (2022).
Meylan, M. et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity 55, 527–541.e525 (2022). This study applied spatial transcriptomics to definitively demonstrate that tumour-reactive plasma cells are derived from intratumoural TLSs.
Petitprez, F. et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577, 556–560 (2020).
Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577, 549–555 (2020).
Hu, C. et al. Tertiary lymphoid structure-associated B cells enhance CXCL13+CD103+CD8+ tissue-resident memory T-cell response to programmed cell death protein 1 blockade in cancer immunotherapy. Gastroenterology 166, 1069–1084 (2024).
Ruffin, A. T. et al. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nat. Commun. 12, 3349 (2021).
Gao, J. et al. Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. Nat. Med. 26, 1845–1851 (2020).
Engblom, C. et al. Spatial transcriptomics of B cell and T cell receptors reveals lymphocyte clonal dynamics. Science 382, eadf8486 (2023).
Vanhersecke, L. et al. Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression. Nat. Cancer 2, 794–802 (2021).
Mei, Y. et al. Single-cell analyses reveal suppressive tumor microenvironment of human colorectal cancer. Clin. Transl. Med. 11, e422 (2021).
Hu, Q. et al. Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling. Nat. Commun. 12, 2186 (2021).
Yang, Y. et al. Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes. Cell 187, 4790–4811.e4722 (2024). Comprehensive multi-omic analysis of tumour-infiltrating B cells across 649 patients and 19 cancer types.
Lu, Y. et al. Complement signals determine opposite effects of B cells in chemotherapy-induced immunity. Cell 180, 1081–1097.e1024 (2020).
Zhu, H. et al. Intratumoral CD38+CD19+B cells associate with poor clinical outcomes and immunosuppression in patients with pancreatic ductal adenocarcinoma. EBioMedicine 103, 105098 (2024).
Meylan, M. et al. Early hepatic lesions display immature tertiary lymphoid structures and show elevated expression of immune inhibitory and immunosuppressive molecules. Clin. Cancer Res. 26, 4381–4389 (2020).
Gunderson, A. J, et al. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer. Oncoimmunology 10, 1900635 (2021).
Gong, L. et al. Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma. Nat. Commun. 12, 1540 (2021).
Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293–1308.e1236 (2018).
Qian, J. et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res. 30, 745–762 (2020).
Olalekan, S., Xie, B., Back, R., Eckart, H. & Basu, A. Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics. Cell Rep. 35, 109165 (2021).
Wang, W. et al. Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer. Clin. Transl. Med. 11, e253 (2021).
Zhang, S., Liu, Z., Wu, D., Chen, L. & Xie, L. Single-cell RNA-seq analysis reveals microenvironmental infiltration of plasma cells and hepatocytic prognostic markers in HCC with cirrhosis. Front. Oncol. 10, 596318 (2020).
Wieland, A. et al. Defining HPV-specific B cell responses in patients with head and neck cancer. Nature 597, 274–278 (2021).
Cillo, A. R. et al. immune landscape of viral- and carcinogen-driven head and neck cancer. Immunity 52, 183–199.e189 (2020).
Lambrechts, D. et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat. Med. 24, 1277–1289 (2018).
Griss, J. et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat. Commun. 10, 4186 (2019).
Hao, D. et al. The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma. Cancer Discov. 12, 2626–2645 (2022).
Xia, J. et al. Single-cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer. Immunology 168, 135–151 (2023).
King, H. W. et al. Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics. Sci. Immunol. 6, eabe6291 (2021).
Ehrhardt, G. R. et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J. Exp. Med. 202, 783–791 (2005).
Bruno, T. C. et al. Antigen-presenting intratumoral B cells affect CD4+ TIL phenotypes in non-small cell lung cancer patients. Cancer Immunol. Res. 5, 898–907 (2017).
Centuori, S. M. et al. Double-negative (CD27−IgD−) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations. J. Transl. Med. 16, 30 (2018).
Wouters, M. C. A. & Nelson, B. H. Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer. Clin. Cancer Res. 24, 6125–6135 (2018).
Biswas, S. et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature 591, 464–470 (2021). This study of a cohort of 534 patients with ovarian cancer demonstrates a protective role for locally produced IgA through a transcytosis mechanism.
Mazor, R. D. et al. Tumor-reactive antibodies evolve from non-binding and autoreactive precursors. Cell 185, 1208–1222.e1221 (2022).
Ng, K. W. et al. Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature 616, 563–573 (2023). This paper demonstrates that tumour-expresssed endogenous retrovirus proteins are a dominant antigenic driver of tumour-infiltrating B cell anticancer immunity.
Montfort, A. et al. A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases. Clin. Cancer Res. 23, 250–262 (2017).
Blixt, O. et al. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis. Breast Cancer Res. 13, R25 (2011).
Rodriguez, A. B. et al. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts. Cell Rep. 36, 109422 (2021).
Schlößer, H. A. et al. B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies. Oncoimmunology 8, e1512458 (2019).
Kasikova, L. et al. Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer. Nat. Commun. 15, 2528 (2024).
Sautès-Fridman, C., Petitprez, F., Calderaro, J. & Fridman, W. H. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat. Rev. Cancer 19, 307–325 (2019).
Deguchi, S. et al. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma. BMC Cancer 22, 699 (2022).
Ali, N. et al. Regulatory T cells in skin facilitate epithelial stem cell differentiation. Cell 169, 1119–1129.e1111 (2017).
Enamorado, M. et al. Immunity to the microbiota promotes sensory neuron regeneration. Cell 186, 607–620.e617 (2023).
Moreau, J. M. et al. Regulatory T cells promote innate inflammation after skin barrier breach via TGF-β activation. Sci. Immunol. 6, eabg2329 (2021).
Wilson, R. P. et al. IgM Plasma cells reside in healthy skin and accumulate with chronic inflammation. J. Investig. Dermatol. 139, 2477–2487 (2019).
Fitzpatrick, Z. et al. Gut-educated IgA plasma cells defend the meningeal venous sinuses. Nature 587, 472–476 (2020).
Palma, J., Tokarz-Deptuła, B., Deptuła, J. & Deptuła, W. Natural antibodies — facts known and unknown. Cent. Eur. J. Immunol. 43, 466–475 (2018).
Penny, H. A. et al. Rhythmicity of intestinal IgA responses confers oscillatory commensal microbiota mutualism. Sci. Immunol. 7, eabk2541 (2022).
Luck, H. et al. Gut-associated IgA+ immune cells regulate obesity-related insulin resistance. Nat. Commun. 10, 3650 (2019).
Conrey, P. E. et al. IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulation. Sci. Immunol. 8, eade2335 (2023).
Metze, D., Kersten, A., Jurecka, W. & Gebhart, W. Immunoglobulins coat microorganisms of skin surface: a comparative immunohistochemical and ultrastructural study of cutaneous and oral microbial symbionts. J. Investig. Dermatol. 96, 439–445 (1991).
Baldan, A. et al. ABCG1 is required for pulmonary B-1 B cell and natural antibody homeostasis. J. Immunol. 193, 5637–5648 (2014).
Shaw, P. X. et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Investig. 105, 1731–1740 (2000).
Wang, P. et al. Tlr9 deficiency in B cells leads to obesity by promoting inflammation and gut dysbiosis. Nat. Commun. 15, 4232 (2024).
Nishimura, S. et al. Adipose natural regulatory B cells negatively control adipose tissue inflammation. Cell Metab. 18, 759–766 (2013).
Shen, L. et al. B-1a lymphocytes attenuate insulin resistance. Diabetes 64, 593–603 (2015).
Zhang, B. et al. B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity. Nature 599, 471–476 (2021).
Zehentmeier, S. & Pereira, J. P. Cell circuits and niches controlling B cell development. Immunol. Rev. 289, 142–157 (2019).
Dwyer, L. J. et al. B cell treatment promotes a neuroprotective microenvironment after traumatic brain injury through reciprocal immunomodulation with infiltrating peripheral myeloid cells. J. Neuroinflammation 20, 133 (2023).
Sîrbulescu, R. F. et al. B cells support the repair of injured tissues by adopting MyD88-dependent regulatory functions and phenotype. FASEB J. 35, e22019 (2021).
Huang, F. et al. B cell subsets contribute to myocardial protection by inducing neutrophil apoptosis after ischemia and reperfusion. JCI Insight 9, e167201 (2024).
Jiao, J. et al. Regulatory B cells improve ventricular remodeling after myocardial infarction by modulating monocyte migration. Basic Res. Cardiol. 116, 46 (2021).
Frede, A. et al. B cell expansion hinders the stroma-epithelium regenerative cross talk during mucosal healing. Immunity 55, 2336–2351.e2312 (2022).
Lynall, M. E. et al. B-cells are abnormal in psychosocial stress and regulate meningeal myeloid cell activation. Brain Behav. Immun. 97, 226–238 (2021).
Adamo, L. et al. Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart. JCI Insight 5, e134700 (2020).
Lee, D. S. W., Rojas, O. L. & Gommerman, J. L. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat. Rev. Drug Discov. 20, 179–199 (2021).
Bashford-Rogers, R. J. M. et al. Analysis of the B cell receptor repertoire in six immune-mediated diseases. Nature 574, 122–126 (2019).
Croitoru, D. et al. Clinical manifestations and treatment outcomes of pyoderma gangrenosum following rituximab exposure: a systematic review. J. Am. Acad. Dermatol. 87, 655–656 (2022).
Americo, J. L., Cotter, C. A., Earl, P. L., Liu, R. & Moss, B. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection. Proc. Natl Acad. Sci. USA 119, e2202069119 (2022). This study describes a tissue-targeted vaccine strategy to drive mucosal immunity through the application of intranasal boosters.
Wellford, S. A. et al. Mucosal plasma cells are required to protect the upper airway and brain from infection. Immunity 55, 2118–2134.e2116 (2022).
Iwasaki, A. Immune regulation of antibody access to neuronal tissues. Trends Mol. Med. 23, 227–245 (2017).
Zhang, M. et al. Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment. Clin. Exp. Rheumatol. 37, 906–914 (2019).
Benschop, R. J. et al. Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. MAbs 11, 1175–1190 (2019).
Tur, C. et al. CD19-CAR T-cell therapy induces deep tissue depletion of B cells. Ann. Rheum. Dis. https://doi.org/10.1136/ard-2024-226142 (2024).
Zhao, R. et al. cGAS-activated endothelial cell-T cell cross-talk initiates tertiary lymphoid structure formation. Sci. Immunol. 9, eadk2612 (2024).
Chelvanambi, M., Fecek, R. J., Taylor, J. L. & Storkus, W. J. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. J. Immunother. Cancer 9, e001906 (2021).
Johansson-Percival, A. et al. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors. Nat. Immunol. 18, 1207–1217 (2017).
Ramachandran, M. et al. Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma. Cancer Cell 41, 1134–1151.e1110 (2023).
An, D. et al. LTβR agonism promotes anti-tumor immune responses via modulation of the tumor microenvironment. Cancer Res. https://doi.org/10.1158/0008-5472.can-23-2716 (2024).
Acknowledgements
The authors thank the reviewers for their valuable suggestions and the Oregon Health & Science University Immunology Journal Club and Research in Progress for helpful discussion. Research support is provided by the National Institutes of Health (NIH) T32GM142619, Melanoma Research Alliance, LEO Foundation and the Knight Cancer Institute and Department of Molecular Microbiology & Immunology at Oregon Health & Science University (OHSU).
Author information
Authors and Affiliations
Contributions
A.S. and G.C. contributed equally to all aspects of the article. All authors contributed to literature searching, writing and discussion of manuscript content. J.M.M. and L.B.R. developed the overall concept and provided supervision.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Immunology thanks Ziv Shulman and the other, anonymous, reviewers for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Samiea, A., Celis, G., Yadav, R. et al. B cells in non-lymphoid tissues. Nat Rev Immunol (2025). https://doi.org/10.1038/s41577-025-01137-6
Accepted:
Published:
DOI: https://doi.org/10.1038/s41577-025-01137-6